Resistance to Androgen-Pathway Drugs in Prostate Cancer

被引：28
作者：
Sendur, Mehmet A. N. [1 ]
Akinci, Muhammed B. [1 ]
Yalcin, Bulent [1 ]
机构：
[1] Yildirim Beyazit Univ, Ankara, Turkey
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 371卷 / 23期
关键词：
D O I：
10.1056/NEJMc1412594
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2233 / 2233
页数：1
相关论文
共 2 条
[1]   AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer [J].
Antonarakis, Emmanuel S. ;
Lu, Changxue ;
Wang, Hao ;
Luber, Brandon ;
Nakazawa, Mary ;
Roeser, Jeffrey C. ;
Chen, Yan ;
Mohammad, Tabrez A. ;
Chen, Yidong ;
Fedor, Helen L. ;
Lotan, Tamara L. ;
Zheng, Qizhi ;
De Marzo, Angelo M. ;
Isaacs, John T. ;
Isaacs, William B. ;
Nadal, Rosa ;
Paller, Channing J. ;
Denmeade, Samuel R. ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Luo, Jun .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :1028-1038
[2]   Personalizing treatment in patients with castrate-resistant prostate cancer: A study of predictive factors for secondary endocrine therapies activity [J].
Loriot, Yohann ;
Massard, Christophe ;
Albiges, Laurence ;
Di Palma, Mario ;
Blanchard, Pierre ;
Bossi, Alberto ;
Chauchereau, Anne ;
Escudier, Bernard J. ;
Fizazi, Karim .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
1